ClinicalTrials.gg
Sign In

Takotsubo Cardiomyopathy clinical trials

The registry lists 63 studies for Takotsubo Cardiomyopathy across more than 10 countries. 26 are recruiting or about to start. 48 of them are mainly about Takotsubo Cardiomyopathy (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.

Get an email when these change. Save the Takotsubo Cardiomyopathy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
24
Recruiting
23
Status unknown
8
Not yet recruiting
3
Active, not recruiting
3
Terminated
2

Phase

Phase 2
3
Phase 4
3
Phase 1
1

Where

United States
11
Italy
9
United Kingdom
9
Germany
6
Switzerland
5
Sweden
5

Who runs them

University of Aberdeen (6) · University of Edinburgh (3) · Mayo Clinic (3) · Assistance Publique - Hôpitaux de Paris (3) · University of Zurich (3) · Sahlgrenska University Hospital (3) · Ospedale San Giovanni Bellinzona (2) · University of Campania Luigi Vanvitelli (2)

What is being tested here

Drugs under test in Takotsubo Cardiomyopathy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Adenosine102
Bisoprolol101
Valsartan101
Sacubitril101
Dapagliflozin101
Cyclosporine101
Dipyridamole101
Apixaban101
Thioctic Acid001
Acetylcarnitine001

Coming up

0phase 3 studies under way
6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Who these studies take

Of the 23 Takotsubo Cardiomyopathy studies recruiting now, 19 (83%) set no upper age limit and 0 (0%) stop at 75 or younger. 3 (13%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (13%) take healthy volunteers.

Recruiting studies that take each age, of 23
AgeWomenMen
103 (13%)3 (13%)
1821 (91%)21 (91%)
3022 (96%)22 (96%)
4023 (100%)23 (100%)
5023 (100%)23 (100%)
6523 (100%)23 (100%)
7523 (100%)23 (100%)
8522 (96%)22 (96%)

Across all 63 studies, recruiting or not: 5% stop at 75 or younger and 0% at 65; 10% take children; 6% are for women only and 0% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Takotsubo Cardiomyopathy studies take

Of 25 observational studies under Takotsubo Cardiomyopathy, half reached primary completion within 50 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Observational50 mo40–… · 25 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 63. Browse all 63 → or search them.